Liver X receptors and female reproduction: When cholesterol meets fertility!

Journal of Endocrinological Investigation

Volumn 36, Issue 1, 2013, Pages 55-60

  Lobaccaro, J M A ^a,b,c,d   Gallot, D ^a,e   Lumbroso, S ^f   Mouzat, K ^f  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CNRS   (France)

^c Faculté de Médecine   (France)

^d CRNH AUVERGNE   (France)

^e Laboratoire de Biologie de la Reproduction et CECOS   (France)

^f NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer; Cholesterol; Female reproduction; LXR

Indexed keywords

CHOLESTEROL; FULVESTRANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIGAND; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; LUPROSTIOL; OXYSTEROL; OXYTOCIN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER PROGNOSIS; CESAREAN SECTION; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HOMEOSTASIS; HUMAN; HYPOCHOLESTEROLEMIA; NONHUMAN; OVARY; OVARY CANCER; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVULATION; PHYSIOLOGICAL PROCESS; PREGNANCY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REPRODUCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STEROIDOGENESIS; SUPEROVULATION; UTERUS; UTERUS CONTRACTILITY; UTERUS CONTRACTION;

CHOLESTEROL; FEMALE; FERTILITY; HUMANS; MALE; ORPHAN NUCLEAR RECEPTORS; REPRODUCTION;

EID: 84873576067     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8765     Document Type: Review

References (50)

1. Gwynne JT, Strauss JF 3rd. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982, 3: 299-329.
2. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232: 34-47.
3. Grummer RR, Carroll DJ. A review of lipoprotein cholesterol metabolism: importance to ovarian function. J Anim Sci 1988, 66: 3160-73.
4. Robins ED, Nelson LM, Hoeg JM. Aberrant hypothalamic-pituitaryovarian axis in the Watanabe heritable hyperlipidemic rabbit. J Lipid Res 1994, 35: 52-9.
5. Miettinen HE, Rayburn H, Krieger M. Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J Clin Invest 2001, 108: 1717-22.
6. Kolmakova A, Wang J, Brogan R, Chaffin C, Rodriguez A. Deficiency of scavenger receptor class B type I negatively affects progesterone secretion in human granulosa cells. Endocrinology 2010, 151: 5519-27.
7. Robker RL, Wu LL, Yang X. Inflammatory pathways linking obesity and ovarian dysfunction. J Reprod Immunol 2011, 88: 142-8.
8. Cardozo E, Pavone ME, Hirshfeld-Cytron JE. Metabolic syndrome and oocyte quality. Trends Endocrinol Metab 2011, 22: 103-9.
9. Byskov AG, Andersen CY, Leonardsen L. Role of meiosis activating sterols, MAS, in induced oocyte maturation. Mol Cell Endocrinol 2002, 187: 189-96.
10. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology-a systematic review. Hum Reprod Update 2007, 13: 433-44.
11. Ferlitsch K, Sator MO, Gruber DM, Rücklinger E, Gruber CJ, Huber JC. Body mass index, follicle-stimulating hormone and their predictive value in in vitro fertilization. J Assist Reprod Genet 2004, 21: 431-6.
12. Csapo A. Progesterone block. Am J Anat 1956, 98: 273-91.
13. Mendelson CR. Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Mol Endocrinol 2009, 23: 947-54.
14. Poobalan AS, Aucott LS, Gurung T, Smith WC, Bhattacharya S. Obesity as an independent risk factor for elective and emergency caesarean delivery in nulliparous women-systematic review and meta-analysis of cohort studies. Obes Rev 2009, 10: 28-35.
15. Cedergren MI. Non-elective caesarean delivery due to ineffective uterine contractility or due to obstructed labour in relation to maternal body mass index. Eur J Obstet Gynecol Reprod Biol 2009, 145: 163-6.
16. Knopp RH, Warth MR, Charles D, et al. Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes. Biol Neonate 1986, 50: 297-317.
17. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. Faseb J 2002, 16: 1348-60.
18. Mouzat K, Baron S, Marceau G, et al. Emerging roles for LXRs and LRH-1 in female reproduction. Mol Cell Endocrinol 2012, Jun 28 [Epub ahead of print]; doi: 10.1016/j.mce.2012.06.009.
19. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001, 81: 629-83.
20. Viennois E, Pommier AJ, Mouzat K, et al. Targeting liver X receptors in human health: deadlock or promising trail? Expert Opin Ther Targets 2011, 15: 219-32.
21. Bookout AL, Mangelsdorf DJ. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 2003, 1: e012.
22. Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000, 16: 459-81.
23. Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro JM, Baron S. Selective liver X receptor modulators (SLiMs): What use in human health? Mol Cell Endocrinol 2012, 351: 129-41.
24. Legry V, Cottel D, Ferrieres J, et al. Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations. Int J Obes (Lond) 2008, 32: 421-8.
25. Robitaille J, Houde A, Lemieux S, Gaudet D, Pérusse L, Vohl MC. The lipoprotein/lipid profile is modulated by a gene-diet interaction effect between polymorphisms in the liver X receptor-alpha and dietary cholesterol intake in French-Canadians. Br J Nutr 2007, 97: 11-8.
26. Solaas K, Legry V, Retterstol K, et al. Suggestive evidence of associations between liver X receptor beta polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe). BMC Med Genet 2010, 11: 144.
27. Dahlman I, Nilsson M, Jiao H, et al. Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet Genomics 2006, 16: 881-9.
28. Mouzat K, Volat F, Baron S, et al. Absence of nuclear receptors for oxysterols liver X receptor induces ovarian hyperstimulation syndrome in mice. Endocrinology 2009, 150: 3369-75.
29. Drouineaud V, Sagot P, Garrido C, et al. Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists. Mol Hum Reprod 2007, 13: 373-9.
30. Cummins CL, Volle DH, Zhang Y, et al. Liver X receptors regulate adrenal cholesterol balance. J Clin Invest 2006, 116: 1902-12.
31. Volle DH, Lobaccaro JM. Role of the nuclear receptors for oxysterols LXRs in steroidogenic tissues: beyond the "foie gras", the steroids and sex? Mol Cell Endocrinol 2007, 265-266: 183-9.
32. Volle DH, Mouzat K, Duggavathi R, et al. Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol Endocrinol 2007, 21: 1014-27.
33. Bogan RL, Debarber AE, Hennebold JD. Liver x receptor modulation of gene expression leading to proluteolytic effects in primate luteal cells. Biol Reprod 2012, 86: 89.
34. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxys-terol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996, 383: 728-31.
35. Grondahl C. Oocyte maturation. Basic and clinical aspects of in vitro maturation (IVM) with special emphasis of the role of FF-MAS. Dan Med Bull 2008, 55: 1-16.
36. Steffensen KR, Robertson K, Gustafsson JA, Andersen CY. Reduced fertility and inability of oocytes to resume meiosis in mice deficient of the Lxr genes. Mol Cell Endocrinol 2006, 256: 9-16.
37. Grøndahl C, Ottesen JL, Lessl M, et al. Meiosis-activating sterol promotes resumption of meiosis in mouse oocytes cultured in vitro in contrast to related oxysterols. Biol Reprod 1998, 58: 1297-302.
38. Homburg R, Insler V. Ovulation induction in perspective. Hum Reprod Update 2002, 8: 449-62.
39. Budev MM, Arroliga AC, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med 2005, 33 (10 Suppl): S301-6.
40. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003, 9: 213-9.
41. Mouzat K, Prod'homme M, Volle DH, et al. Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus. J Biol Chem 2007, 282: 4693-701.
42. Pothiwala P, Jain SK, Yaturu S. Metabolic syndrome and cancer. Metab Syndr Relat Disord 2009, 7: 279-88.
43. Li AJ, Elmore RG, Chen IY, Karlan BY. Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers. Gynecol Oncol 2010, 116: 78-81.
44. Elmore RG, Ioffe Y, Scoles DR, Karlan BY, Li AJ. Impact of statin therapy on survival in epithelial ovarian cancer. Gynecol Oncol 2008, 111: 102-5.
45. Scoles DR, Xu X, Wang H, et al. Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein. Gynecol Oncol 2010, 116: 109-16.
46. Vigushin DM, Dong Y, Inman L, et al. The nuclear oxysterol receptor LXRalpha is expressed in the normal human breast and in breast cancer. Med Oncol 2004, 21: 123-31.
47. Vedin LL, Lewandowski SA, Parini P, Gustafsson JA, Steffensen KR. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 2009, 30: 575-9.
48. El Roz A, Bard JM, Huvelin JM, Nazih H. LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. Anticancer Res 2012, 32: 3007-13.
49. Pommier AJ, Alves G, Viennois E, et al. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 2010, 29: 2712-23.
50. Lappano R, Recchia AG, De Francesco EM, et al. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor alpha-mediated signaling in cancer cells and in cardiomyocytes. PLoS One 2011, 6: e16631.